The Implications of Treatment Delays in Adjuvant Therapy for Resected Cholangiocarcinoma Patients

ConclusionsWe identified characteristics that are related to the timing of adjuvant therapy in patients with biliary cancers. There was an OS decrement associated with delays beyond the median time point of 59  days. This finding may be especially relevant given the treatment delays seen as a result of COVID-19.
Source: Journal of Gastrointestinal Cancer - Category: Cancer & Oncology Source Type: research